Rufei Shen

603 total citations
19 papers, 336 citations indexed

About

Rufei Shen is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Rufei Shen has authored 19 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Rufei Shen's work include Pituitary Gland Disorders and Treatments (5 papers), Growth Hormone and Insulin-like Growth Factors (5 papers) and Adrenal and Paraganglionic Tumors (4 papers). Rufei Shen is often cited by papers focused on Pituitary Gland Disorders and Treatments (5 papers), Growth Hormone and Insulin-like Growth Factors (5 papers) and Adrenal and Paraganglionic Tumors (4 papers). Rufei Shen collaborates with scholars based in China, United States and Israel. Rufei Shen's co-authors include Hongting Zheng, Min Long, Hua Qu, Xing Li, Linlin Zhang, Shaodong Guo, Jun Wu, Xiuli Wang, Dao Wen Wang and Lun Tan and has published in prestigious journals such as Medicine, Oncotarget and Frontiers in Endocrinology.

In The Last Decade

Rufei Shen

18 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rufei Shen China 10 135 111 90 67 62 19 336
Lamia Amoura France 8 102 0.8× 123 1.1× 49 0.5× 56 0.8× 23 0.4× 16 311
Jürgen Weiß Germany 12 96 0.7× 161 1.5× 130 1.4× 99 1.5× 82 1.3× 19 406
Can Pang China 9 97 0.7× 71 0.6× 127 1.4× 67 1.0× 135 2.2× 14 414
Hannes Manell Sweden 10 222 1.6× 76 0.7× 112 1.2× 177 2.6× 115 1.9× 21 433
Anna Kleyman United Kingdom 9 106 0.8× 119 1.1× 57 0.6× 55 0.8× 113 1.8× 14 411
Shunkui Luo China 9 72 0.5× 129 1.2× 71 0.8× 36 0.5× 144 2.3× 15 325
Christine Cugnet‐Anceau France 9 86 0.6× 79 0.7× 77 0.9× 58 0.9× 91 1.5× 19 399
Fusheng Fang China 11 109 0.8× 100 0.9× 44 0.5× 56 0.8× 30 0.5× 45 309
Pia Fahlbusch Germany 11 100 0.7× 164 1.5× 113 1.3× 62 0.9× 196 3.2× 16 411
N. Bellili France 9 75 0.6× 104 0.9× 70 0.8× 98 1.5× 63 1.0× 11 290

Countries citing papers authored by Rufei Shen

Since Specialization
Citations

This map shows the geographic impact of Rufei Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rufei Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rufei Shen more than expected).

Fields of papers citing papers by Rufei Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rufei Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rufei Shen. The network helps show where Rufei Shen may publish in the future.

Co-authorship network of co-authors of Rufei Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Rufei Shen. A scholar is included among the top collaborators of Rufei Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rufei Shen. Rufei Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Zhang, Dongdong, et al.. (2025). A Report of Primary Pyogenic Ventriculitis Caused by Streptococcus Constellatus Diagnosed by Metagenomic Next-Generation Sequencing. Infection and Drug Resistance. Volume 18. 1209–1214.
2.
Wang, Congrong, Yan Wang, Chengcheng Huang, et al.. (2025). The role of dysregulated copper metabolism in diabetes and its complications: a review. Frontiers in Endocrinology. 16. 1681001–1681001. 1 indexed citations
3.
Shen, Rufei, et al.. (2024). Efficacy of GnRH Pulses in Hypogonadism Secondary to Primary Empty Sella: Case Report. Reproductive Sciences. 31(12). 3892–3898. 1 indexed citations
4.
Liu, Jingpeng, Xiaoqing Zhang, Yong Chen, et al.. (2023). Differences in Clinical Characteristics and Surgical Outcomes of Patients with Ischemic and Hemorrhagic Pituitary Adenomas. Journal of Korean Neurosurgical Society. 66(1). 72–81. 2 indexed citations
5.
Li, Xing, Hao Zhang, Ling Zhou, et al.. (2023). Effects and plasma proteomic analysis of GLP-1RA versus CPA/EE, in combination with metformin, on overweight PCOS women: a randomized controlled trial. Endocrine. 83(1). 227–241. 13 indexed citations
6.
Li, Xing, et al.. (2022). Identification of Key Genes and Pathways in Peripheral Blood Mononuclear Cells of Type 1 Diabetes Mellitus by Integrated Bioinformatics Analysis. Diabetes & Metabolism Journal. 46(3). 451–463. 9 indexed citations
7.
Lv, Yangfan, Dandan Li, Rufei Shen, et al.. (2022). Pleiomorphism plurihormonal Pit-1-positive macroadenoma with central hyperthyroidism: a rare case report and literature review. BMC Endocrine Disorders. 22(1). 325–325. 1 indexed citations
8.
Li, Xing, Yuanyuan Zhou, Weixing Li, et al.. (2022). Clinical Characteristics and Associated Factors of Colonic Polyps in Acromegaly. Experimental and Clinical Endocrinology & Diabetes. 130(11). 714–722. 4 indexed citations
9.
Chen, Guangmin, et al.. (2021). Case Report: A Deletion Variant in the DCAF17 Gene Underlying Woodhouse-Sakati Syndrome in a Chinese Consanguineous Family. Frontiers in Genetics. 12. 741323–741323. 1 indexed citations
10.
Zheng, Xingwu, Xuefeng Tang, Zhenle Zang, et al.. (2021). Potential biomarkers and lncRNA-mRNA regulatory networks in invasive growth hormone-secreting pituitary adenomas. Journal of Endocrinological Investigation. 44(9). 1947–1959. 10 indexed citations
11.
Feng, Xiaoli, et al.. (2020). Short-Term Versus 6-Week Prednisone In The Treatment Of Subacute Thyroiditis: A Randomized Controlled Trial. Endocrine Practice. 26(8). 900–908. 13 indexed citations
12.
Zhang, Hexuan, Qiang Li, Xiaoli Liu, et al.. (2020). Adrenal artery ablation for primary aldosteronism without apparent aldosteronoma: An efficacy and safety, proof‐of‐principle trial. Journal of Clinical Hypertension. 22(9). 1618–1626. 28 indexed citations
13.
Shen, Rufei, et al.. (2018). A novel chimeric CYP11B2/CYP11B1 combined with a new p.L340P CYP11B1 mutation in a patient with 11OHD: case report. BMC Endocrine Disorders. 18(1). 23–23. 5 indexed citations
14.
Hu, Jintao, Jun Yan, Xingwu Zheng, et al.. (2018). Magnetic resonance spectroscopy may serve as a presurgical predictor of somatostatin analog therapy response in patients with growth hormone-secreting pituitary macroadenomas. Journal of Endocrinological Investigation. 42(4). 443–451. 9 indexed citations
15.
Li, Xing, Rufei Shen, Linlin Zhang, et al.. (2018). Plasma Asprosin Levels Are Associated with Glucose Metabolism, Lipid, and Sex Hormone Profiles in Females with Metabolic-Related Diseases. Mediators of Inflammation. 2018. 1–12. 106 indexed citations
16.
Long, Min, Hua Qu, Rufei Shen, et al.. (2018). DPP-4 Inhibitors as Treatments for Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Journal of Diabetes Research. 2018. 1–10. 39 indexed citations
17.
Zang, Zhenle, Zheng Zhou, Jintao Hu, et al.. (2017). Metformin inhibits proliferation and growth hormone secretion of GH3 pituitary adenoma cells. Oncotarget. 8(23). 37538–37549. 31 indexed citations
18.
Huang, Jin, Lun Tan, Rufei Shen, et al.. (2016). Decreased Peripheral Mitochondrial DNA Copy Number is Associated with the Risk of Heart Failure and Long-term Outcomes. Medicine. 95(15). e3323–e3323. 52 indexed citations
19.
You, Ling, Lun Tan, Lei Liu, et al.. (2015). ADAMTS7 locus confers high cross-race risk for development of coronary atheromatous plaque. Molecular Genetics and Genomics. 291(1). 121–128. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lamia Amoura Breakdown of academic impact, for papers by Jürgen Weiß Breakdown of academic impact, for papers by Can Pang Breakdown of academic impact, for papers by Hannes Manell Breakdown of academic impact, for papers by Anna Kleyman Breakdown of academic impact, for papers by Shunkui Luo Breakdown of academic impact, for papers by Christine Cugnet‐Anceau Breakdown of academic impact, for papers by Fusheng Fang Breakdown of academic impact, for papers by Pia Fahlbusch Breakdown of academic impact, for papers by N. Bellili
Rankless by CCL
2026